Aβ1-40 but not Aβ1-42 levels in cortex correlate with apolipoprotein E ε4 allele dosage in sporadic Alzheimer's disease

Brain Research

Volumn 748, Issue 1-2, 1997, Pages 250-252

  Ishii, Kazuhiro ^a,b   Tamaoka, Akira ^b   Mizusawa, Hidehiro ^b   Shoji, Shin Ichi ^b   Ohtake, Toshiyuki ^c   Fraser, Peter E ^d   Takahashi, Hitoshi ^e   Tsuji, Shoji ^e   Gearing, Maria ^f   Mizutani, Toshio ^g   Yamada, Shigeo ^g   Kato, Masanori ^h   St George Hyslop, Peter H ^d   Mirra, Suzanne S ^f   Mori, Hiroshi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^d UNIVERSITY OF TORONTO   (Canada)

^e NIIGATA UNIVERSITY   (Japan)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^h Soga Hospital   (Japan)

Author keywords

A 1 40; Alzheimer's disease; apolipoprotein E; late onset: sporadic

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); APOLIPOPROTEIN E4; PEPTIDE FRAGMENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; ALLELE; GENE DOSAGE; GENETICS; METABOLISM; MIDDLE AGED;

AGED; ALLELES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CEREBRAL CORTEX; GENE DOSAGE; HUMANS; MIDDLE AGED; PEPTIDE FRAGMENTS;

EID: 0030615092     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01363-7     Document Type: Article

References (23)

1. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Perick-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261 (1993) 921-923.
2. Dewji, N.N. and Singer, S.J., Genetic clues to Alzheimer's disease, Science, 271 (1996) 159-160.
3. Gearing, M., Mori, H. and Mirra, S.S., Aβ-peptide length and apolipoprotein E genotype in Alzheimer's disease, Ann. Neurol., 39 (1996) 395-399.
4. Gearing, M., Schneider, J.A., Robbins, R.S., Hollister, R.D., Mori, H., Games, D., Hyman, B.T. and Mirra, S.S., Regional variation in the distribution of apolipoprotein E and Aβ in Alzheimer's disease, J. Neuropathol. Exp. Neurol., 54 (1995) 833-841.
5. Goate, A., Chartier-Harlin, M.C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., Mant, R., Newton, P., Rooke, K., Roques, P., Talbot, C., Pericak-Vance, M., Roses, A., Williamson, R., Rossor, M., Owen, M. and Hardy, J., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer' s disease, Nature, 349 (1991) 704-706.
6. Greenberg, S.M., Rebeck, G.W., Vonstattle, J.P.G., Gomez-Isla, T. and Hyman, B.T., Apolipoprotein E ∈4 and cerebral hemorrhage associated with amyloid angiopathy, Ann. Neurol., 38 (1995) 254-259.
7. Hixson, J.E. and Vernier, D.T., Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, J. Lipid Res., 31 (1990) 545-548.
8. Iwatsubo, T., Mann, D.M.A., Odaka, A., Suzuki, N. and Ihara, Y., Amyloid β protein(Aβ) deposition: Aβ 42(43) precedes Aβ40 in Down syndrome, Ann. Neurol., 37 (1995) 294-299.
9. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N. and Ihara, Y., Visualization of Aβ 42 (43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42 (43), Neuron, 13 (1994) 45-53.
10. Jarrett, J.T., Lansbury, P.T., Jr., Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell, 73 (1993) 1055-1058.
11. Levy, L.E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Yu, C.E., Jondro, P.D., Schmidt, S.D., Wang, K., Crowley, A.C., Fu, Y.-H., Guenette, S.Y., Galas, D., Nemens, E., Wijsman, E.M., Bird, T.D., Schellenberg, G.D. and Tanzi, R.E., Candidate gene for the chromosome 1 familial Alzheimer's disease locus, Science, 269 (1995) 973-977.
12. Ma, J., Yee, A., Brewer, H.B., Das, S. and Potter, H., Amyloid-associated proteins al-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments, Nature, 372 (1994) 92-94.
13. Rebeck, G.W., Reiter, J.S., Strickland, D.K. and Hyman, B.T., Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions, Neuron, 11 (1993) 575-580.
14. Rogaev, E.I., Sherrington, R., Rogaeva, W.A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., Mar, L., Sorbi, S., Nacmias, B., Piacentini, S., Amaducci, L., Chumakov, I., Cohen, D., Lannfelt, L., Fraser, P.E., Rommens, J.M. and St. George-Hyslop, P.H., Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene, Nature, 376 (1995) 775-778.
15. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D. and Younkin, S., Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease, Nature Med., 2 (1996) 864-670.
16. Schmechel, D.E., Saunders, A.M., Strittmatter, W.J., Grain, B.J., Hulette, C.M., Joo, S.H., Pericak-Vance, M.A., Goldgaber, D. and Roses, A.D., Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90 (1993) 9649-9653.
17. Strittmatter, W.J., Saunders, A.M., Schmechel, D.E., Pericak-Vance, M., Enghild, J., Salvesen, G.S. and Roses, A.D., Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90 (1993) 1977-1981.
18. Sherrington R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, Ikeda, M., Chi, H., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A.C., Montesi, M.P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R.J., Wasco, W., Da Silva, H.A.R., Haines, J.L., Pericak-Vance, M.A., Tanzi, R.E., Roses, A.D., Fraser, P.E., Rommens, J.M. and St. George-Hyslop, P.H., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature, 375 (1995) 754-760.
19. Suzuki, N., Cheung, T.T., Cai, X.-D., Odaka, A., Otvos, L. Jr., Eckman, C., Golde, T.E. and Younkin, S.G., An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants, Science, 264 (1994) 1336-1340.
20. Tamaoka, A., Kondo, T., Odaka, A., Sahara, N., Sawamura, N., Ozawa, K., Suzuki, N., Shoji, S. and Mori, H., Biochemical evidence for the long-tail form (Aβ1-42/43) of amyloid β protein as a seed molecule in cerebral deposits of Alzheimer's disease, Biochem. Biophys. Res. Commun., 205 (1994) 834-842.
21. Tamaoka, A., Odaka, A., Ishibashi, Y., Usami, M., Sahara, N., Suzuki, N., Nukina, N., Mizusawa, H., Shoji, S., Kanazawa, I. and Mori, H., APP717 missense mutation affects the ratio of amyloid β protein species (Aβ1-42/43 and Aβ1-40) in familial Alzheimer's disease brain, J. Biol. Chem., 269 (1994) 32721-32724.
22. Tamaoka, A., Sawamura, N., Odaka, A., Suzuki, N., Mizusawa, H., Shoji, S. and Mori, H., Amyloid β protein 1-42/43 (Aβ1-42/43) in cerebellar diffuse plaques: Enzyme-linked immunosorbent assay and immunocytochemical study, Brain Res., 679 (1995) 151-156.
23. Younkin, S.G., Evidence that A beta;342 is the real culprit in Alzheimer's disease, Ann. Neurol., 37 (1995) 287-288.